Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?
Goette
Andreas
A
D000818:Animals; D001281:Atrial Fibrillation / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation; D003094:Collagen / Q000378:metabolism; D004285:Dogs; D015536:Down-Regulation; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D005355:Fibrosis; D006325:Heart Atria / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D035683:MicroRNAs / Q000378:metabolism*; D009538:Nicotine / Q000009:adverse effects*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D000077294:Receptor, Transforming Growth Factor-beta Type II; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism; D018125:Receptors, Transforming Growth Factor beta / Q000378:metabolism; D012907:Smoking / Q000009:adverse effects*; D053773:Transforming Growth Factor beta1 / Q000378:metabolism; D015854:Up-Regulation; D064569:alpha7 Nicotinic Acetylcholine Receptor
C579167:Chrna7 protein, human; D035683:MicroRNAs; D011978:Receptors, Nicotinic; D018125:Receptors, Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D064569:alpha7 Nicotinic Acetylcholine Receptor; D009538:Nicotine; D003094:Collagen; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II